Mizuho Medy Co Ltd
TSE:4595

Watchlist Manager
Mizuho Medy Co Ltd Logo
Mizuho Medy Co Ltd
TSE:4595
Watchlist
Price: 2 289 JPY -0.82% Market Closed
Market Cap: 34.4B JPY

Mizuho Medy Co Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mizuho Medy Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Mizuho Medy Co Ltd
TSE:4595
Cash from Operating Activities
¥3.5B
CAGR 3-Years
-18%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Cash from Operating Activities
¥211.9B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
10%
Olympus Corp
TSE:7733
Cash from Operating Activities
¥152B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
9%
Sysmex Corp
TSE:6869
Cash from Operating Activities
¥76.2B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
7%
Nihon Kohden Corp
TSE:6849
Cash from Operating Activities
¥21.7B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
6%
JEOL Ltd
TSE:6951
Cash from Operating Activities
¥23.1B
CAGR 3-Years
2%
CAGR 5-Years
42%
CAGR 10-Years
9%
No Stocks Found

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Mizuho Medy Co Ltd Intrinsic Value
HIDDEN
Show

See Also

What is Mizuho Medy Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
3.5B JPY

Based on the financial report for Jun 30, 2025, Mizuho Medy Co Ltd's Cash from Operating Activities amounts to 3.5B JPY.

What is Mizuho Medy Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
44%

Over the last year, the Cash from Operating Activities growth was 9%. The average annual Cash from Operating Activities growth rates for Mizuho Medy Co Ltd have been -18% over the past three years , 44% over the past five years .

Back to Top